Physician

David Mark Trask, M.D.

According to 2025 Medicare claims, David Trask, M.D. (NPI: 1174592349) practices dermatology in the Medford, OR market, with the plurality of this provider's patient population coming from Jackson, OR. Trask uses personal NPI as billing NPI and primary practice location at 97504-8144. Trask is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Trask's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,970 traditional Medicare patients, billed 18,739 HCPCS/CPT codes, and received $660,442 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,204 prescription claims across 525 beneficiaries totaling $31,124 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 16 records totaling $605. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $71,972 to $31,124. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$444K$888K2015 Medicare payment: $598,035 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $582,971 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $688,557 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $696,347 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $888,355 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $696,819 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $678,678 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $631,993 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $706,343 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $660,442 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,91819,981$598,035
20162,02720,544$582,971
20171,99621,886$688,557
20182,19122,014$696,347
20192,35726,129$888,355
20202,17321,371$696,819
20212,10420,381$678,678
20222,06720,975$631,993
20232,10621,736$706,343
20241,97018,739$660,442

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$36K$72K2015 Drug cost: $71,972 (USD; Tot_Drug_Cst)2016 Drug cost: $61,499 (USD; Tot_Drug_Cst)2017 Drug cost: $58,836 (USD; Tot_Drug_Cst)2018 Drug cost: $56,290 (USD; Tot_Drug_Cst)2019 Drug cost: $46,675 (USD; Tot_Drug_Cst)2020 Drug cost: $36,072 (USD; Tot_Drug_Cst)2021 Drug cost: $30,050 (USD; Tot_Drug_Cst)2022 Drug cost: $29,933 (USD; Tot_Drug_Cst)2023 Drug cost: $29,424 (USD; Tot_Drug_Cst)2024 Drug cost: $31,124 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154981,162$71,972
20165051,140$61,499
20175041,144$58,836
20186401,316$56,290
20196161,324$46,675
20205121,216$36,072
20215221,130$30,050
20224651,116$29,933
20235071,166$29,424
20245251,204$31,124

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths9531,322$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,3352,432$62
17000Destruction of precancer skin growth, 1 growth1,0191,545$31
88305Pathology examination of tissue using a microscope, intermediate complexity1,4753,371$29
17003Destruction of precancer skin growth, 2-14 growths9007,154$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil692,019$4,410
MetronidazoleMetronidazole572,073$4,243
Triamcinolone AcetonideTriamcinolone Acetonide2449,942$2,272
Betamethasone DipropionateBetamethasone Dipropionate481,399$1,885
KetoconazoleKetoconazole772,633$1,509

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$605Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Mark Trask, M.D.?

Tedicare shows public-source Medicare data for David Mark Trask, M.D. (NPI 1174592349), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Mark Trask, M.D. have ACO affiliation data?

David Mark Trask, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to David Mark Trask, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does David Mark Trask, M.D. have Open Payments data?

David Mark Trask, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.